RJL systems QUANTUM V SEGMENTAL BIA, Руководство пользователя, Страница: 3 / 21

About Us – RJL Systems
RJL SYSTEMS WAS THE FIRST COMPANY TO DEVELOP THE USE OF BIOELECTRICAL
IMPEDANCE ANALYSIS (BIA) TO ASSESS HUMAN BODY COMPOSITION BY
ENGINEERING THE “GOLD STANDARD” OF BIA INSTRUMENTS IN 1981. RJL ANALYZERS
PROVIDE BIA MEASUREMENTS FOR USERS AROUND THE WORLD – THEY ARE
RECOGNIZED AS “RESEARCH QUALITY” BECAUSE OF THEIR REPUTATION FOR
ACCURACY AND RELIABILITY.
RJL has registered patents on our instruments, trademarks, and copyrights on our software and papers.
Customers are buying products directly from the company that develops, engineers, and manufactures
the analyzers – NOT a third party vendor or distributor.
RJL’s Quantum Analyzers have FDA clearance as a Class II medical device for safe use on the human
body to collect BIA data. RJL is registered with the FDA as a Medical Device Manufacturer
(Registration No. 1831675). The Quantum V Segmental BIA System and accompanying software are
marketed under the following FDA clearances: K830292C, K862383, and K070999.
RJL Systems is registered as an ISO-13485 2016 compliant company.
RJL instruments go through a rigorous testing, calibration and inspection process that complies with
ISO standards. Conformity of products and services to International Standards provides assurance about
overall product quality, safety, reliability and accuracy
Any questions or technical support needed regarding our products will be handled by the professionals
who designed and built the analyzers, and the related software
The Company’s 30+ years of engineering expertise and knowledge in BIA science make it uniquely
qualified to provide custom-made instruments of any size or scope
If you sign up for the e-mail newsletter (via website), you will receive information on interesting new
developments in the field of BIA science and/or RJL products (www.rjlsystems.com).
All RJL products come with a warranty and continued technical and product support.
- 3 -